SIGLEC1 (CD169) as a potential diagnostical screening marker for monogenic interferonopathies

Pediatr Allergy Immunol. 2021 Apr;32(3):621-625. doi: 10.1111/pai.13400. Epub 2020 Nov 9.

Banu Orak^{1

2}, Gonza Ngoumou^{1

2}, Frédéric Ebstein³, Barbara Zieba³, Carl Christoph Goetzke^{1

4

5}, Ellen Knierim^{2

6}, Angela M Kaindl^{2

6

7}, Axel Panzer⁸, Manuela Theophil⁸, Monika Berns⁹, Elke Krüger³, Christian Meisel¹⁰, Nadine Unterwalder¹⁰, Tilmann Kallinich^{1

2

4

5}

¹ Pediatric Pneumology, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
² Center for Chronically Sick Children (SPZ), Charité - Universitätsmedizin Berlin, Berlin, Germany.
³ University Medicine Greifswald, Institute of Medical Biochemistry and Molecular Biology, Greifswald, Germany.
⁴ Berlin Institute of Health (BIH), Berlin, Germany.
⁵ Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute (DRFZ), Berlin, Germany.
⁶ Pediatric Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
⁷ Charité - Universitätsmedizin Berlin, Institute of Cell Biology and Neurobiology, Berlin, Germany.
⁸ DRK Kliniken Berlin, Westend, Germany.
⁹ Department for Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹⁰ Immunology Department, Labor Berlin - Charité Vivantes GmbH, Berlin, Germany.

No abstract available

Publication types